Print
Email
Print Edition StoriesThursday, March 5, 2009
AdvanSource Biomaterials CFO Walters steps down
By Mass High Tech Staff
MHT's Marc Songini: RI plans launch of cord blood center
Rodney Brown on NECN: Hacking into medical devices
Medical device material company AdvanSource Biomaterials Corp. reports that CFO Eric Walters has resigned to “pursue other personal interests,” and the Wilmington-based company has named David Volpe as interim CFO.
According to president and CEO Michael Adams, Walters joined AdvanSource (NYSE: ASB) in October 2005. Walters, for his part, said in a statement that he enjoyed working at the company.
AdvanSource Biomaterials was known as CardioTech International Inc. until last year. The company is currently testing its CardioPass synthetic coronary artery bypass graft in U.S. and European clinical trials.
In April of 2008, AdvanSource sold its Catheter and Disposables Technology Inc. subsidiary to Tacpro Inc. for $1.2 million, and in July 2007, it sold its Gish Biomedical Inc. subsidiary to Medos Medizintechnik AG for $7.5 million. For fiscal 2008, AdvanSource reported a net loss of $6 million on total revenue of $3.2 million.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
